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Abstract This case series describes a new optical coher-
ence tomography (OCT) specific observation relevant to
the differential diagnosis of patients with suspected optic
neuritis. A tiny prefoveal floater, only detectable by OCT,
was found responsible for the symptoms in three patients,
one of whom had been referred with unilateral delayed
visual evoked potentials. This case series suggests that with
increased use of OCT in routine clinical care, entoptic
phenomena can be demonstrated as a relevant differential
diagnosis to optic neuritis. Patients should be explained the
benign nature of their symptoms.
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Introduction
Should optical coherence tomography (OCT) be part of the
routine clinical assessment is a controversially debated
topic in the neuro-ophthalmology community [1]. There
are good arguments against routine use of OCT [2, 3], and
situations were a good case can be made for it [4, 5]. This
series of cases referred to use with suspected optic neuritis,
highlights that OCT is also useful to diagnose dormant
entopic phenomena, which can be confusing for both
patients and physicians.
Entoptic phenomena due to floaters, synonymous mou-
ches volantes or vitreous opacities are common. They can
result in shadowing artefacts on the retina [6, 7]. Patients
who present with a visual field defect (VFD) may have a
so-called floater scotoma [8]. The differential diagnosis
includes retinal and optic nerve pathology [5].
Case series
Case review of three subsequent patients is seen between
November and December 2014 in Amsterdam and London.
Macular volume scans were conducted with spectral-do-
main OCT (Heidelberg Spectralis at both Institutions).
Case 1
A 39-year-old, myopic (-6 dpt in both eyes) man experi-
enced a central scotoma in his right eye for the past year.
The central scotoma considerably interfered with his work
on a computer screen. He described a grey/black spot
which he could clearly delineate it on an Amsler chart (see
Fig. 1a). The scotoma extended to approximately
2.2 9 1.3 of visual angle and was static centrally, but
moved in an about 45 angle to the periphery.
His best-corrected visual acuity (BCVA) was 0.6 on the
right and 1.0 on the left. Optic neuritis was sus-
pected elsewhere and visual evoked potentials (VEP) were
performed. Because of an asymmetric latency of the VEP
(108.6 ms on the right, compared to 101.4 ms on the left),
he was referred to us for suspected optic neuritis. The
macular volume OCT scan showed vitreous opacifications
in front of the fovea (Fig. 1b). The location and shape
corresponded to the scotoma seen on the Amsler
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chart (Fig. 1a). The size of the floater (which was 777 lm
from the fovea) on OCT was approximately 1035 lm,
whereas the size of the perceived floater on the Amsler
chart (at a viewing distance of about 30 cm) was 29 mm,
therefore the enlargement perceived by the patient was 28
times.
Case 2
A 41-year-old IT-consultant had experienced photopsia in
his good right eye which were followed by a small greyish
smear or patch in his central vision. The relative scotoma
did interfere with reading. The left eye was amblyopic. He
had also experienced ocular pain and was referred to
us with suspected optic neuritis. Whilst the recurrent
photopsia and peri-ocular pain could be explained by a
visual aura and migraine, the static VFD could not. The
VFD was located slightly inferior to the centre in the right
eye. Whilst he could see through the smear, he found it
difficult to read a text message on his smart phone
(Fig. 1c). Revision of his previous three serial macular
volume OCT scans reproducibly showed a small prefoveal
floater which did only cast a very faint shadow (Fig. 1d–f).
Case 3
A 67-year-old man reported progressive visual decline
and VFD in his right eye. His BCVA was 0.4 on the right
and 0.8 on the left. He was referred with a suspected optic
neuropathy. On clinical examination there was also sig-
nificant bilateral cataract. Fundoscopy was normal. The
automatic perimetry showed decreased central sensitivity.
Colour vision was normal. Brain MRI did show normal
signal and size of the optic pathways. After being referred
to us, retinal OCT imaging revealed a small prefoveal
floater and fibrosis of the internal limiting membrane
(Fig. 1g). Note that despite the small size of this floater
the optical density is high which cast a shadow that is
clearly seen through all retinal layer in the central
foveola.
Discussion
Referrals to a neuro-ophthalmology unit include optic
neuritis and optic neuropathies [1, 2, 5]. This case series
shows that small prefoveal floaters just dense enough to
cast a shadow on the retina were the cause for the patients’
central scotomas.
There were features which understandably lead to a
referral diagnosis of optic neuritis or another optic
Fig. 1 a Amsler chart, case 1. A central scotoma, due to a prefoveal
floater, extending to 2.2 9 1.3 of visual angle on the Amsler
chart held at about 30 cm distance such that one square corresponds to
1. bOptical coherence tomography, case 1. A prefoveal floater is seen
on the right (cSLO). The 25 vertical green lines correspond to
subsequent OCT B-scans on an approximate 30 field. The distance
between the individual lines calculates to 1.2. The floater measures
about 3.6 9 1.2 on the cSLO image. This prefoveal floater corre-
sponds to the mirror image shown on the Amsler chart in a. d Central
scotoma in case 2. The small, relative central scotomamakes it difficult
to read small print textmessages on his smart phone. The text for the city
of ‘‘London’’ is obscuredwhilst focusing on thewords ‘‘nice sunny’’. e–
f Serial OCT was taken over a 9-month period. One small prefoveal
floater remains in exactly the exact same place at three-month follow-up
visits. g The very small prefoveal floater in case 3 casts a dense shadow
in the OCT image, which is not visible on the sCLO image on the right,
but can be seen on the OCT B-scan on the left (colour figure online)
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neuropathy. Further investigation either by automatic
perimetry and results of the VEP, seemingly supported the
referral diagnosis. There are however a large number of
reasons why VEPs can be delayed and a prefoveal floater
causing reduced visual acuity may be added to the list
including poor refraction, cataract, migraine and many
other causes [5].
Floater scotomas may occur in eyes with or without
posterior vitreous detachment (PVD), incomplete PVD or
vitreous cysts [7, 8]. To this list small prefoveal floaters
only detectable by OCT may be added. Prefoveal floaters
differ from typical mouches volantes as their location does
not permit for the so typical lateral movements clearly
described for larger and more distally located floaters.
Tentatively one may suggest the term ‘mouches dorman-
tes’ (French ‘dormant’ translates to ‘sleeping’) as they
seem to lay sleeping until detection by OCT.
With regard to patient management the most relevant
point is to explain the benign nature of a floater. If the
vision of a patient is severely effected by a large floater,
pars plana vitrectomy can be effective. For the small pre-
foveal floaters reported here, there is a lack of evidence for
both surgical and laser invention. One group performed a
Nd:YAG laser posterior hyaloidotomy for a premacular
vitreous floater with poor outcome [9]. Therefore we do not
recommend any invasive procedures for small prefoveal
floaters. Likewise, ocriplasmin which can induce posterior
vitreous detachment is currently not advocated for floaters.
We suspect that with the increasing use of handheld
visual devices requiring a pristine central visual field (such
as smart phones and tablets), more of these ‘mouche dor-
mants’ will be recognised by broader routine clinical use of
OCT. For patients this implies that they can be reassured
about the benign nature of their symptoms, rather than
remaining anxious about potentially sinister neurological
pathology in absence of evidence to the contrary.
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